Parkinson, the second most neurological degenerative diseases in the world, affects more than 10 million people around the world, 200,000 in Brazil alone. Despite its great occurrence, a complete understanding of its causes and the possibilities of healing still represents a challenge to the scientific community.
“It is a multi -factor disease because you have genetic problems, you have environmental problems that have already been proven such as pesticides, pesticide exhibition as a cause,” Sarah Kasgari, a neurologist at Das Clinikas Hospital.
The diversity of the factors participating in the development of this situation has led to interesting discoveries. Sarah indicates that a genetic type of disease has been identified that does not contain alpha synoclion, and is an important sign. This finds challenging traditional concepts and stimulating new search lines.
The expert refers to a change in the concentration of discussions in international conferences that involve the sub -species of Parkinson with the genetic classification, the classification of images and the classification of metabolic signs and vital signs. A approach that goes beyond the tremor, not the tremor.
The future of Parkinson’s diagnosis and treatment will refer to a more individual approach. The expert expects a more detailed description: “We will not call Parkinson. We will give the patient, alpha cineoclin, vibrate, we will add a clinic, a picture, and vital indicators to treat it with careful medicine.”
This personal approach is to revolutionize the treatment of the disease, allowing more specific and possibly more effective interventions for every patient.
